Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / Common Stock, $0.01 par value per share
-
Shares outstanding
-
107,228,372
-
Number of holders
-
169
-
Total 13F shares, excl. options
-
61,903,041
-
Shares change
-
+6,767,669
-
Total reported value, excl. options
-
$3,394,932,061
-
Value change
-
+$434,519,153
-
Put/Call ratio
-
159%
-
Number of buys
-
101
-
Number of sells
-
-52
-
Price
-
$54.84
Significant Holders of ROCKET PHARMACEUTICALS, INC. - Common Stock, $0.01 par value per share (RCKT) as of Q4 2020
183 filings reported holding RCKT - ROCKET PHARMACEUTICALS, INC. - Common Stock, $0.01 par value per share as of Q4 2020.
ROCKET PHARMACEUTICALS, INC. - Common Stock, $0.01 par value per share (RCKT) has 169 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 61,903,041 shares
of 107,228,372 outstanding shares and own 58% of the company stock.
Largest 10 shareholders include RTW INVESTMENTS, LP (17,060,211 shares), PRICE T ROWE ASSOCIATES INC /MD/ (3,479,321 shares), PERCEPTIVE ADVISORS LLC (3,396,867 shares), BlackRock Inc. (2,968,720 shares), TANG CAPITAL MANAGEMENT LLC (2,965,485 shares), WELLINGTON MANAGEMENT GROUP LLP (2,681,521 shares), RA CAPITAL MANAGEMENT, L.P. (2,136,081 shares), VANGUARD GROUP INC (2,037,459 shares), WESTFIELD CAPITAL MANAGEMENT CO LP (1,594,981 shares), and LORD, ABBETT & CO. LLC (1,590,052 shares).
This table shows the top 169 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.